Akcea Therapeutics, Inc.

Q2 2018 13F Holders

Symbol
AKCA
CUSIP
00972L107
Type
Equity
Class
COM
Num filings
63
Total reported value, excl. options
$541 M
Manager Report Date Value ($000) Shares Option Type